Taurolidine (TRD)
Taurolidine ([bis(1,1-dioxoperhydro-1,2,4-thiadiazinyl-4)-methane) is a drug with antimicrobial and anti-lipopolysaccharide properties. Derived from the amino acid taurine, its immunue modulatory action is reported to be mediated with priming and activation of macrophages and polymorphonuclear leukocytes.Taurolidine has been used to treat patients with peritonitis and as an antiendoxic agent in patients with systemic inflammatory response syndrome. Additionally, taurolidine demonstrates some anti-tumor properties, with positive results seen in early-stage clinical investigations using the drug to treat gastrointestinal malignancies and tumors of the central nervous system.Taurolidine has been investigated for the prevention of central venous catheter-related infections, and there is ample evidence that the addition of taurolidine significantly decreases infection rates.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Taurolidine (TRD) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Taurolidine (TRD) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Taurolidine (TRD) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Taurolidine (TRD) CLIA Kit Customized Service Offer
n/a ELISA Kit for Taurolidine (TRD) ELISA Kit Customized Service Offer